OTC Markets Group (OTCM)
(Delayed Data from OTC)
$51.99 USD
-0.56 (-1.07%)
Updated Apr 19, 2024 03:57 PM ET
4-Sell of 5 4
D Value A Growth C Momentum B VGM
Income Statements
Fiscal Year end for OTC Markets Group Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 107 | 102 | 100 | 68 | 60 |
Cost Of Goods | 6 | 6 | 9 | 3 | 1 |
Gross Profit | 101 | 96 | 91 | 65 | 60 |
Selling & Adminstrative & Depr. & Amort Expenses | 69 | 59 | 53 | 44 | 42 |
Income After Depreciation & Amortization | 33 | 37 | 38 | 21 | 18 |
Non-Operating Income | 1 | 0 | 0 | 0 | 0 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | 34 | 37 | 38 | 21 | 18 |
Income Taxes | 6 | 6 | 7 | 3 | 3 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 28 | 31 | 30 | 18 | 15 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 28 | 31 | 30 | 18 | 15 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 35 | 39 | 40 | 23 | 19 |
Depreciation & Amortization (Cash Flow) | 2 | 2 | 2 | 2 | 1 |
Income After Depreciation & Amortization | 33 | 37 | 38 | 21 | 18 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 11.86 | 11.89 | 11.81 | 11.63 | 11.70 |
Diluted EPS Before Non-Recurring Items | 2.28 | 2.53 | 2.52 | 1.53 | 1.25 |
Diluted Net EPS (GAAP) | 2.28 | 2.53 | 2.52 | 1.53 | 1.25 |
Fiscal Year end for OTC Markets Group Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 26.77 | 26.23 | 26.42 | 27.23 |
Cost Of Goods | NA | 1.33 | 1.15 | 1.26 | 1.79 |
Gross Profit | NA | 25.44 | 25.08 | 25.17 | 25.45 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 16.63 | 16.50 | 16.87 | 18.52 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 8.81 | 8.58 | 8.30 | 6.93 |
Non-Operating Income | NA | 0.26 | 0.23 | 0.26 | 0.15 |
Interest Expense | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | NA | 9.07 | 8.81 | 8.56 | 7.07 |
Income Taxes | NA | 2.06 | 1.43 | 1.60 | 0.75 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 7.00 | 7.38 | 6.96 | 6.32 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 7.00 | 7.38 | 6.96 | 6.32 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 11.87 | 11.87 | 11.86 | 11.87 |
Diluted EPS Before Non-Recurring Items | -99,999.00 | 0.58 | 0.61 | 0.57 | 0.52 |
Diluted Net EPS (GAAP) | -99,999.00 | 0.58 | 0.61 | 0.57 | 0.52 |